Sabra Healthcare Reit (SBRA) has disclosed a new risk, in the Regulation category.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sabra Healthcare REIT has reported that there have been no material changes in their assessment of risk factors as outlined in their 2024 Annual Report on Form 10-K. This suggests that the company perceives its risk environment to be stable, with no new significant threats identified. Investors and stakeholders should consider this stability in risk assessment when evaluating the company’s future performance. However, it remains crucial to monitor any potential developments that could alter this risk landscape.
The average SBRA stock price target is $19.40, implying 6.71% upside potential.
To learn more about Sabra Healthcare Reit’s risk factors, click here.